HEADER TRANSFERASE 09-AUG-06 2HZN TITLE ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: P150, C-ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 5 1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ABL1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,G.FENDRICH,J.LIEBETANZ,D.FABBRO,P.MANLEY REVDAT 5 30-AUG-23 2HZN 1 REMARK SEQADV REVDAT 4 18-OCT-17 2HZN 1 REMARK REVDAT 3 27-JUL-11 2HZN 1 REMARK VERSN REVDAT 2 24-FEB-09 2HZN 1 VERSN REVDAT 1 16-JAN-07 2HZN 0 JRNL AUTH S.W.COWAN-JACOB,G.FENDRICH,A.FLOERSHEIMER,P.FURET, JRNL AUTH 2 J.LIEBETANZ,G.RUMMEL,P.RHEINBERGER,M.CENTELEGHE,D.FABBRO, JRNL AUTH 3 P.W.MANLEY JRNL TITL STRUCTURAL BIOLOGY CONTRIBUTIONS TO THE DISCOVERY OF DRUGS JRNL TITL 2 TO TREAT CHRONIC MYELOGENOUS LEUKAEMIA. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 63 80 2007 JRNL REFN ISSN 0907-4449 JRNL PMID 17164530 JRNL DOI 10.1107/S0907444906047287 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 8864 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.267 REMARK 3 R VALUE (WORKING SET) : 0.264 REMARK 3 FREE R VALUE : 0.314 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 422 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 94.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 80.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.16 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 DUE TO A FEATURE IN THE REFINEMENT PROGRAM, THE STRUCTURE WAS REMARK 3 REFINED WITH OXT ON ONE OR MORE RESIDUES THAT IS NOT THE TERMINAL REMARK 3 RESIDUE OF THE SEQUENCE. IN ALL THESE INSTANCES THE OXT WAS REMARK 3 CHANGED TO N OF THE NEXT RESIDUE. REMARK 3 DUE TO THE HIGH OVERALL TEMPERATURE FACTOR IN THESE CRYSTALS THE REMARK 3 DENSITY MAPS LOOKED MUCH LOWER RESOLUTION THAN 2.7 A. AS A RESULT, REMARK 3 NO WATER MOLECULES WERE ADDED. THE ELECTRON DENSITY FOR THE REMARK 3 INHIBITOR IS WEAK, BUT DEFINITELY PRESENT. THE HIGH OVERALL B- REMARK 3 VALUE IS PROBABLY CORRELATED WITH THE DIFFICULTY IN GETTING A REMARK 3 MODEL WHICH GIVES A LOW R-FACTOR FOR THIS CRYSTAL FORM. REMARK 4 REMARK 4 2HZN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038952. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 94 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8602 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY: 2HYY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16 % PEG 8000, 0.1 M NACACODYLATE PH REMARK 280 6.2, 0.2 M MGACETATE, MICROBATCH UNDER OIL, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 52.71550 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.17900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.58950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 52.71550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 82.76850 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 82.76850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.71550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.58950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 52.71550 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.17900 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 52.71550 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 55.17900 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 52.71550 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 82.76850 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 27.58950 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 52.71550 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 27.58950 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 82.76850 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 52.71550 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 52.71550 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 55.17900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 223 REMARK 465 ALA A 224 REMARK 465 GLY A 251 REMARK 465 GLN A 252 REMARK 465 TYR A 253 REMARK 465 LYS A 274 REMARK 465 GLU A 275 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 LYS A 512 REMARK 465 ARG A 513 REMARK 465 GLY A 514 REMARK 465 THR A 515 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 238 CD OE1 OE2 REMARK 470 LYS A 262 NZ REMARK 470 LYS A 263 CD CE NZ REMARK 470 TYR A 264 CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 281 CG CD OE1 OE2 REMARK 470 LYS A 356 NZ REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLU A 466 CG CD OE1 OE2 REMARK 470 ILE A 502 CA C O CB CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 230 C - N - CD ANGL. DEV. = -15.5 DEGREES REMARK 500 HIS A 396 N - CA - C ANGL. DEV. = -17.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 229 151.93 -44.18 REMARK 500 MET A 244 158.94 -47.24 REMARK 500 LYS A 245 -127.00 -135.84 REMARK 500 HIS A 295 146.65 -173.19 REMARK 500 CYS A 305 76.11 -158.80 REMARK 500 ILE A 313 102.44 -163.64 REMARK 500 VAL A 335 65.18 -111.61 REMARK 500 ARG A 362 -26.87 87.41 REMARK 500 ASP A 363 55.44 -148.13 REMARK 500 THR A 389 -18.07 -148.73 REMARK 500 ASP A 391 -2.95 -155.20 REMARK 500 ALA A 397 -149.19 45.56 REMARK 500 ALA A 399 -145.13 -160.25 REMARK 500 PRO A 402 87.96 -65.94 REMARK 500 PRO A 408 -72.01 -50.93 REMARK 500 TYR A 440 63.50 36.82 REMARK 500 ASP A 455 60.37 80.83 REMARK 500 SER A 501 -110.82 -168.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KIN A 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HYY RELATED DB: PDB REMARK 900 RELATED ID: 2HZ0 RELATED DB: PDB REMARK 900 RELATED ID: 2HZ4 RELATED DB: PDB REMARK 900 RELATED ID: 2HZI RELATED DB: PDB DBREF 2HZN A 229 515 UNP Q61258 ABL1_MOUSE 229 515 SEQADV 2HZN GLY A 223 UNP Q61258 CLONING ARTIFACT SEQADV 2HZN ALA A 224 UNP Q61258 CLONING ARTIFACT SEQADV 2HZN MET A 225 UNP Q61258 CLONING ARTIFACT SEQADV 2HZN ASP A 226 UNP Q61258 CLONING ARTIFACT SEQADV 2HZN PRO A 227 UNP Q61258 CLONING ARTIFACT SEQADV 2HZN SER A 228 UNP Q61258 CLONING ARTIFACT SEQRES 1 A 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 A 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 A 293 GLU LEU GLY LYS ARG GLY THR HET KIN A 600 27 HETNAM KIN 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL) HETNAM 2 KIN PHENYL]UREA FORMUL 2 KIN C19 H14 F3 N3 O2 HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 LYS A 263 SER A 265 5 3 HELIX 3 3 GLU A 279 LYS A 291 1 13 HELIX 4 4 ASN A 322 CYS A 330 1 9 HELIX 5 5 SER A 336 LYS A 357 1 22 HELIX 6 6 ALA A 365 ARG A 367 5 3 HELIX 7 7 GLU A 373 HIS A 375 5 3 HELIX 8 8 GLY A 383 MET A 388 1 6 HELIX 9 9 ALA A 407 ASN A 414 1 8 HELIX 10 10 SER A 417 THR A 434 1 18 HELIX 11 11 ASP A 444 SER A 446 5 3 HELIX 12 12 GLN A 447 LYS A 454 1 8 HELIX 13 13 PRO A 465 TRP A 476 1 12 HELIX 14 14 SER A 485 SER A 500 1 16 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 GLU A 255 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 268 N GLY A 259 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O THR A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 2 CYS A 369 VAL A 371 0 SHEET 2 B 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 TYR A 393 HIS A 396 0 SHEET 2 C 2 ALA A 399 PRO A 402 -1 O PHE A 401 N THR A 394 CISPEP 1 PRO A 309 PRO A 310 0 0.48 SITE 1 AC1 13 ALA A 269 GLU A 286 MET A 290 LEU A 298 SITE 2 AC1 13 VAL A 299 THR A 315 GLU A 316 PHE A 317 SITE 3 AC1 13 MET A 318 LEU A 370 VAL A 379 ALA A 380 SITE 4 AC1 13 ASP A 381 CRYST1 105.431 105.431 110.358 90.00 90.00 90.00 I 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009485 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009485 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009061 0.00000